At a recent event organized by that consortium, the New Jersey Alliance for Clinical and Translational Science(NJACTS), leaders from academia, healthcare, government and the pharmaceutical industry discussed the future of scientific and clinical trial innovation in the state. These new innovations will result from a $33-million grant from the National Institutes of Health (NIH). To read the full story.
Recent Posts
- Researchers Pitch Strategies to Identify Potential Fraudulent Participants in Online Qualitative Research.
- Alzheimer’s Research Center Receives $1.5 Million to Launch Physician-Scientist Program.
- Report Finds Broad Adoption of AI in New Jersey – and Strong Support for Regulation.
- Knowing Your Family’s Surgical History Might Be Key to Preventing Emergency Gallbladder Surgery.
- Join NJACTS for a Special Populations Seminar on 2/17 at 1pm
Categories
- Community (2,436)
- Covid (996)
- CTO Events (6)
- News (3,084)
- Pilots (21)